The treatment of WHO Category 1 tuberculosis with 2HRZE/6HE is indeed defensible

Affiliations

Comment

R Mathew et al. Int J Tuberc Lung Dis. 2000 Sep.

. 2000 Sep;4(9):795.

No abstract available

Comment in

More on the question of optimal chemotherapy in the presence of isoniazid resistance.
Long R, Scalcini M. Long R, et al. Int J Tuberc Lung Dis. 2000 Sep;4(9):890-4. Int J Tuberc Lung Dis. 2000. PMID: 10985663 No abstract available.

A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre.
[No authors listed] [No authors listed] Int J Tuberc Lung Dis. 1997 Dec;1(6):509-17. Int J Tuberc Lung Dis. 1997. PMID: 9487448 Clinical Trial.
Is the treatment of WHO category I tuberculosis with 2HRZE/6HE a defensible practice?
Long R, Scalcini M. Long R, et al. Int J Tuberc Lung Dis. 1999 Sep;3(9):747-8. Int J Tuberc Lung Dis. 1999. PMID: 10488879 No abstract available.